Literature DB >> 34743990

Regulation of NAD+ metabolism in aging and disease.

Xiaogang Chu1, Raghavan Pillai Raju2.   

Abstract

More than a century after discovering NAD+, information is still evolving on the role of this molecule in health and diseases. The biological functions of NAD+ and NAD+ precursors encompass pathways in cellular energetics, inflammation, metabolism, and cell survival. Several metabolic and neurological diseases exhibit reduced tissue NAD+ levels. Significantly reduced levels of NAD+ are also associated with aging, and enhancing NAD+ levels improved healthspan and lifespan in animal models. Recent studies suggest a causal link between senescence, age-associated reduction in tissue NAD+ and enzymatic degradation of NAD+. Furthermore, the discovery of transporters and receptors involved in NAD+ precursor (nicotinic acid, or niacin, nicotinamide, and nicotinamide riboside) metabolism allowed for a better understanding of their role in cellular homeostasis including signaling functions that are independent of their functions in redox reactions. We also review studies that demonstrate that the functional effect of niacin is partially due to the activation of its cell surface receptor, GPR109a. Based on the recent progress in understanding the mechanism and function of NAD+ and NAD+ precursors in cell metabolism, new strategies are evolving to exploit these molecules' pharmacological potential in the maintenance of metabolic balance.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NAD; Niacin; Niacin receptor; Nicotinamide adenine mononucleotide; Nicotinamide riboside

Mesh:

Substances:

Year:  2021        PMID: 34743990      PMCID: PMC8649045          DOI: 10.1016/j.metabol.2021.154923

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  149 in total

Review 1.  Modulating NAD+ metabolism, from bench to bedside.

Authors:  Elena Katsyuba; Johan Auwerx
Journal:  EMBO J       Date:  2017-08-07       Impact factor: 11.598

2.  (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G.

Authors:  Andrew K P Taggart; Jukka Kero; Xiaodong Gan; Tian-Quan Cai; Kang Cheng; Marc Ippolito; Ning Ren; Rebecca Kaplan; Kenneth Wu; Tsuei-Ju Wu; Lan Jin; Chen Liaw; Ruoping Chen; Jeremy Richman; Daniel Connolly; Stefan Offermanns; Samuel D Wright; M Gerard Waters
Journal:  J Biol Chem       Date:  2005-06-01       Impact factor: 5.157

3.  Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice.

Authors:  Julien Hanson; Andreas Gille; Sabrina Zwykiel; Martina Lukasova; Björn E Clausen; Kashan Ahmed; Sorin Tunaru; Angela Wirth; Stefan Offermanns
Journal:  J Clin Invest       Date:  2010-07-26       Impact factor: 14.808

4.  Molecular identification of nicotinic acid receptor.

Authors:  Takatoshi Soga; Masazumi Kamohara; Jun Takasaki; Shun-ichiro Matsumoto; Tetsu Saito; Takahide Ohishi; Hideki Hiyama; Ayako Matsuo; Hitoshi Matsushime; Kiyoshi Furuichi
Journal:  Biochem Biophys Res Commun       Date:  2003-03-28       Impact factor: 3.575

Review 5.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 6.  Cardiac Energy Metabolism in Heart Failure.

Authors:  Gary D Lopaschuk; Qutuba G Karwi; Rong Tian; Adam R Wende; E Dale Abel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

7.  Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.

Authors:  Aaron N Long; Katrina Owens; Anna E Schlappal; Tibor Kristian; Paul S Fishman; Rosemary A Schuh
Journal:  BMC Neurol       Date:  2015-03-01       Impact factor: 2.474

8.  Effect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial.

Authors:  Roberto S Kalil; Jeffrey H Wang; Ian H de Boer; Roy O Mathew; Joachim H Ix; Arif Asif; Xuefeng Shi; William E Boden
Journal:  Kidney Int       Date:  2015-02-04       Impact factor: 10.612

9.  Equilibrative Nucleoside Transporters Mediate the Import of Nicotinamide Riboside and Nicotinic Acid Riboside into Human Cells.

Authors:  Andrey Kropotov; Veronika Kulikova; Kirill Nerinovski; Alexander Yakimov; Maria Svetlova; Ljudmila Solovjeva; Julia Sudnitsyna; Marie E Migaud; Mikhail Khodorkovskiy; Mathias Ziegler; Andrey Nikiforov
Journal:  Int J Mol Sci       Date:  2021-01-30       Impact factor: 5.923

10.  Effects of extended-release niacin with laropiprant in high-risk patients.

Authors:  Martin J Landray; Richard Haynes; Jemma C Hopewell; Sarah Parish; Theingi Aung; Joseph Tomson; Karl Wallendszus; Martin Craig; Lixin Jiang; Rory Collins; Jane Armitage
Journal:  N Engl J Med       Date:  2014-07-17       Impact factor: 91.245

View more
  3 in total

Review 1.  Diet, Gut Microbiome, and Cognitive Decline.

Authors:  Susan Ettinger
Journal:  Curr Nutr Rep       Date:  2022-08-26

Review 2.  Nicotinamide adenine dinucleotide and the sirtuins caution: Pro-cancer functions.

Authors:  Raymond D Palmer; Mauro Vaccarezza
Journal:  Aging Med (Milton)       Date:  2021-11-30

3.  Association of Human Whole Blood NAD+ Contents With Aging.

Authors:  Fan Yang; Xuan Deng; Ye Yu; Lei Luo; Xianda Chen; Jinping Zheng; Yugang Qiu; Feng Xiao; Xiaomei Xie; Yuzheng Zhao; Jun Guo; Feifei Hu; Xuguang Zhang; Zhenyu Ju; Yong Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-21       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.